UnitedHealth starts run of 1st-quarter earnings reports for big health insurers on Thursday
Shares of UnitedHealth Group Inc. (NYSE:UNH) surged on Tuesday as it declared that it will give investors and analysts an initial seem at how 2013 is developing for health insurers at what time it declares Q1 results on Thursday.
Big hospital chains similar to HCA Holdings Inc. and Health Management Associates Inc. currently declared slow admissions in the Q1, and whereas that’s bad for hospital stocks, it might help the performance of health insurers who conclude with fewer maintains to pay.
UnitedHealth reported previous dropped it would enlarge its reach outside the United States by spending around $4.9B to buy a majority stake in Brazilian health benefits and care provider Amil Participacoes SA. The firm is the biggest health insurer in Brazil and owns hospitals and clinics.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded at $62.81 by increasing +1.98% with price volatility of 1.45% for a week and 1.79% for a month plus price volatility’s Average True Range for 14 days was 1.08 and its beta stands at 0.91 times.
Stocks after opening at $62.18 hit high price of $63.00 and on last session stock held volume of 4.97 million shares which was unexpectedly lower than its average volume of 6.20 million shares.
Short-term as well long term investors always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was debt to equity ratio 0.54 and long-term debt to equity ratio also remained 0.45. The Company had total cash at hand $11.44 billion and a book value per share as $30.60 in the most recent quarter.
While investors who viewing UNH against other stocks with the reference of profit margin that are Express Scripts Holding Company (NASDAQ:ESRX) having profit margin 1.45%, Aetna Inc. (NYSE:AET) with 4.53% profit margin, WellPoint, Inc. (NYSE:WLP) having 4.30% profit margin and Humana Inc (NYSE:HUM) having profit margin of 3.12%.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here